nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—OPRM1—nicotine dependence	0.746	1	CbGaD
Tramadol—C-reactive protein increased—Varenicline—nicotine dependence	0.012	0.058	CcSEcCtD
Tramadol—Change of bowel habit—Varenicline—nicotine dependence	0.0087	0.0419	CcSEcCtD
Tramadol—Chest wall pain—Varenicline—nicotine dependence	0.00549	0.0265	CcSEcCtD
Tramadol—Emotional disorder—Varenicline—nicotine dependence	0.00459	0.0221	CcSEcCtD
Tramadol—Mental retardation—Varenicline—nicotine dependence	0.00459	0.0221	CcSEcCtD
Tramadol—Blood calcium decreased—Varenicline—nicotine dependence	0.00442	0.0213	CcSEcCtD
Tramadol—Rhinitis allergic—Varenicline—nicotine dependence	0.00442	0.0213	CcSEcCtD
Tramadol—Abnormal faeces—Varenicline—nicotine dependence	0.00351	0.0169	CcSEcCtD
Tramadol—Joint stiffness—Varenicline—nicotine dependence	0.00332	0.016	CcSEcCtD
Tramadol—Peripheral ischaemia—Varenicline—nicotine dependence	0.00275	0.0132	CcSEcCtD
Tramadol—Abnormal behaviour—Varenicline—nicotine dependence	0.00269	0.013	CcSEcCtD
Tramadol—Musculoskeletal chest pain—Varenicline—nicotine dependence	0.00259	0.0125	CcSEcCtD
Tramadol—Dextromethorphan—CHRNB4—nicotine dependence	0.00249	0.292	CrCbGaD
Tramadol—Haematochezia—Varenicline—nicotine dependence	0.00249	0.012	CcSEcCtD
Tramadol—Withdrawal symptom—Varenicline—nicotine dependence	0.00244	0.0118	CcSEcCtD
Tramadol—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00244	0.0641	CbGpPWpGaD
Tramadol—Dysphoria—Varenicline—nicotine dependence	0.00232	0.0112	CcSEcCtD
Tramadol—Dextromethorphan—CHRNB2—nicotine dependence	0.00228	0.267	CrCbGaD
Tramadol—Peripheral vascular disorder—Varenicline—nicotine dependence	0.00204	0.00986	CcSEcCtD
Tramadol—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.00204	0.00986	CcSEcCtD
Tramadol—Sinus congestion—Varenicline—nicotine dependence	0.00202	0.00972	CcSEcCtD
Tramadol—Throat irritation—Varenicline—nicotine dependence	0.00199	0.00958	CcSEcCtD
Tramadol—Suicide—Varenicline—nicotine dependence	0.00193	0.00932	CcSEcCtD
Tramadol—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.00191	0.05	CbGpPWpGaD
Tramadol—Night sweats—Varenicline—nicotine dependence	0.00186	0.00896	CcSEcCtD
Tramadol—Urine abnormality—Varenicline—nicotine dependence	0.00181	0.00873	CcSEcCtD
Tramadol—Osteoporosis—Varenicline—nicotine dependence	0.00179	0.00862	CcSEcCtD
Tramadol—Sleep disturbance—Varenicline—nicotine dependence	0.00179	0.00862	CcSEcCtD
Tramadol—Sexual dysfunction—Varenicline—nicotine dependence	0.00179	0.00862	CcSEcCtD
Tramadol—Dextromethorphan—CHRNA3—nicotine dependence	0.00173	0.202	CrCbGaD
Tramadol—Completed suicide—Varenicline—nicotine dependence	0.00171	0.00822	CcSEcCtD
Tramadol—Urine analysis abnormal—Varenicline—nicotine dependence	0.00171	0.00822	CcSEcCtD
Tramadol—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0017	0.0446	CbGpPWpGaD
Tramadol—Platelet count decreased—Varenicline—nicotine dependence	0.00169	0.00813	CcSEcCtD
Tramadol—Vaginal discharge—Varenicline—nicotine dependence	0.00165	0.00795	CcSEcCtD
Tramadol—Toothache—Varenicline—nicotine dependence	0.00165	0.00795	CcSEcCtD
Tramadol—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.00153	0.00738	CcSEcCtD
Tramadol—Upset stomach—Varenicline—nicotine dependence	0.00153	0.00738	CcSEcCtD
Tramadol—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.00151	0.0397	CbGpPWpGaD
Tramadol—Cyst—Varenicline—nicotine dependence	0.0015	0.00723	CcSEcCtD
Tramadol—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.00149	0.00716	CcSEcCtD
Tramadol—Menstrual disorder—Varenicline—nicotine dependence	0.00147	0.00709	CcSEcCtD
Tramadol—Paranoia—Varenicline—nicotine dependence	0.00147	0.00709	CcSEcCtD
Tramadol—Laryngeal pain—Varenicline—nicotine dependence	0.00147	0.00709	CcSEcCtD
Tramadol—Haematemesis—Varenicline—nicotine dependence	0.00144	0.00696	CcSEcCtD
Tramadol—Suicidal ideation—Varenicline—nicotine dependence	0.00143	0.00689	CcSEcCtD
Tramadol—Delusion—Varenicline—nicotine dependence	0.00142	0.00683	CcSEcCtD
Tramadol—Hyperlipidaemia—Varenicline—nicotine dependence	0.00139	0.00671	CcSEcCtD
Tramadol—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00132	0.0348	CbGpPWpGaD
Tramadol—Fungal infection—Varenicline—nicotine dependence	0.0013	0.00626	CcSEcCtD
Tramadol—Mydriasis—Varenicline—nicotine dependence	0.00126	0.00606	CcSEcCtD
Tramadol—Nephrolithiasis—Varenicline—nicotine dependence	0.00125	0.00601	CcSEcCtD
Tramadol—Rhinorrhoea—Varenicline—nicotine dependence	0.00124	0.00597	CcSEcCtD
Tramadol—Endocrine disorder—Varenicline—nicotine dependence	0.00121	0.00583	CcSEcCtD
Tramadol—Disturbance in attention—Varenicline—nicotine dependence	0.00116	0.00558	CcSEcCtD
Tramadol—Accidental injury—Varenicline—nicotine dependence	0.00113	0.00546	CcSEcCtD
Tramadol—Chest discomfort—Varenicline—nicotine dependence	0.00113	0.00546	CcSEcCtD
Tramadol—Viral infection—Varenicline—nicotine dependence	0.00111	0.00535	CcSEcCtD
Tramadol—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.00111	0.00535	CcSEcCtD
Tramadol—Thinking abnormal—Varenicline—nicotine dependence	0.0011	0.00528	CcSEcCtD
Tramadol—Lacrimation increased—Varenicline—nicotine dependence	0.00109	0.00525	CcSEcCtD
Tramadol—Nocturia—Varenicline—nicotine dependence	0.00108	0.00521	CcSEcCtD
Tramadol—Dextromethorphan—CHRNA4—nicotine dependence	0.00107	0.125	CrCbGaD
Tramadol—Dysarthria—Varenicline—nicotine dependence	0.00106	0.00511	CcSEcCtD
Tramadol—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00105	0.0276	CbGpPWpGaD
Tramadol—Coordination abnormal—Varenicline—nicotine dependence	0.00102	0.00492	CcSEcCtD
Tramadol—Pulmonary embolism—Varenicline—nicotine dependence	0.001	0.00483	CcSEcCtD
Tramadol—Blood pressure increased—Varenicline—nicotine dependence	0.001	0.00483	CcSEcCtD
Tramadol—Abnormal dreams—Varenicline—nicotine dependence	0.000991	0.00478	CcSEcCtD
Tramadol—Hyperkalaemia—Varenicline—nicotine dependence	0.000985	0.00475	CcSEcCtD
Tramadol—Eructation—Varenicline—nicotine dependence	0.000985	0.00475	CcSEcCtD
Tramadol—Dextromethorphan—OPRM1—nicotine dependence	0.000982	0.115	CrCbGaD
Tramadol—Influenza like illness—Varenicline—nicotine dependence	0.000974	0.00469	CcSEcCtD
Tramadol—Nightmare—Varenicline—nicotine dependence	0.000968	0.00467	CcSEcCtD
Tramadol—Dry eye—Varenicline—nicotine dependence	0.000926	0.00447	CcSEcCtD
Tramadol—Urine output increased—Varenicline—nicotine dependence	0.000907	0.00437	CcSEcCtD
Tramadol—Hypertonia—Varenicline—nicotine dependence	0.000879	0.00424	CcSEcCtD
Tramadol—Mental disability—Varenicline—nicotine dependence	0.00087	0.0042	CcSEcCtD
Tramadol—Euphoric mood—Varenicline—nicotine dependence	0.000862	0.00415	CcSEcCtD
Tramadol—Lymphadenopathy—Varenicline—nicotine dependence	0.000853	0.00411	CcSEcCtD
Tramadol—Sleep disorder—Varenicline—nicotine dependence	0.000841	0.00405	CcSEcCtD
Tramadol—Diabetes mellitus—Varenicline—nicotine dependence	0.000837	0.00403	CcSEcCtD
Tramadol—Polyuria—Varenicline—nicotine dependence	0.000829	0.004	CcSEcCtD
Tramadol—Deafness—Varenicline—nicotine dependence	0.000814	0.00392	CcSEcCtD
Tramadol—Disorientation—Varenicline—nicotine dependence	0.000814	0.00392	CcSEcCtD
Tramadol—Eczema—Varenicline—nicotine dependence	0.00081	0.0039	CcSEcCtD
Tramadol—Eye pain—Varenicline—nicotine dependence	0.000806	0.00389	CcSEcCtD
Tramadol—Injury—Varenicline—nicotine dependence	0.000792	0.00382	CcSEcCtD
Tramadol—Libido decreased—Varenicline—nicotine dependence	0.000785	0.00378	CcSEcCtD
Tramadol—Hot flush—Varenicline—nicotine dependence	0.000778	0.00375	CcSEcCtD
Tramadol—Amnesia—Varenicline—nicotine dependence	0.000775	0.00374	CcSEcCtD
Tramadol—Increased appetite—Varenicline—nicotine dependence	0.000775	0.00374	CcSEcCtD
Tramadol—Menopausal symptoms—Varenicline—nicotine dependence	0.000771	0.00372	CcSEcCtD
Tramadol—Visual disturbance—Varenicline—nicotine dependence	0.000768	0.0037	CcSEcCtD
Tramadol—Atrial fibrillation—Varenicline—nicotine dependence	0.000768	0.0037	CcSEcCtD
Tramadol—Thirst—Varenicline—nicotine dependence	0.000765	0.00369	CcSEcCtD
Tramadol—Arthritis—Varenicline—nicotine dependence	0.000749	0.00361	CcSEcCtD
Tramadol—Hypoglycaemia—Varenicline—nicotine dependence	0.000746	0.0036	CcSEcCtD
Tramadol—Lethargy—Varenicline—nicotine dependence	0.000743	0.00358	CcSEcCtD
Tramadol—OPRD1—Peptide GPCRs—OPRM1—nicotine dependence	0.000738	0.0194	CbGpPWpGaD
Tramadol—Osteoarthritis—Varenicline—nicotine dependence	0.000728	0.00351	CcSEcCtD
Tramadol—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.000728	0.00351	CcSEcCtD
Tramadol—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.000722	0.00348	CcSEcCtD
Tramadol—Migraine—Varenicline—nicotine dependence	0.000717	0.00345	CcSEcCtD
Tramadol—Affect lability—Varenicline—nicotine dependence	0.000717	0.00345	CcSEcCtD
Tramadol—Psychotic disorder—Varenicline—nicotine dependence	0.000711	0.00343	CcSEcCtD
Tramadol—Irritability—Varenicline—nicotine dependence	0.000695	0.00335	CcSEcCtD
Tramadol—OPRD1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000694	0.0182	CbGpPWpGaD
Tramadol—Urinary retention—Varenicline—nicotine dependence	0.000692	0.00334	CcSEcCtD
Tramadol—Mood swings—Varenicline—nicotine dependence	0.00069	0.00332	CcSEcCtD
Tramadol—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.000688	0.0181	CbGpPWpGaD
Tramadol—Liver function test abnormal—Varenicline—nicotine dependence	0.000672	0.00324	CcSEcCtD
Tramadol—Dry skin—Varenicline—nicotine dependence	0.000667	0.00322	CcSEcCtD
Tramadol—Abdominal pain upper—Varenicline—nicotine dependence	0.000665	0.00321	CcSEcCtD
Tramadol—Hypokalaemia—Varenicline—nicotine dependence	0.000662	0.00319	CcSEcCtD
Tramadol—Breast disorder—Varenicline—nicotine dependence	0.000658	0.00317	CcSEcCtD
Tramadol—Cramp muscle—Varenicline—nicotine dependence	0.000656	0.00316	CcSEcCtD
Tramadol—Nasopharyngitis—Varenicline—nicotine dependence	0.000651	0.00314	CcSEcCtD
Tramadol—HTR2C—Monoamine GPCRs—DRD2—nicotine dependence	0.000648	0.017	CbGpPWpGaD
Tramadol—OPRK1—Peptide GPCRs—OPRM1—nicotine dependence	0.000647	0.017	CbGpPWpGaD
Tramadol—Gastritis—Varenicline—nicotine dependence	0.000644	0.00311	CcSEcCtD
Tramadol—Abdominal distension—Varenicline—nicotine dependence	0.000633	0.00305	CcSEcCtD
Tramadol—Asthma—Varenicline—nicotine dependence	0.000629	0.00303	CcSEcCtD
Tramadol—Dysphagia—Varenicline—nicotine dependence	0.000629	0.00303	CcSEcCtD
Tramadol—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000629	0.0165	CbGpPWpGaD
Tramadol—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00062	0.0163	CbGpPWpGaD
Tramadol—Angina pectoris—Varenicline—nicotine dependence	0.000613	0.00295	CcSEcCtD
Tramadol—OPRK1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000609	0.016	CbGpPWpGaD
Tramadol—Bronchitis—Varenicline—nicotine dependence	0.000605	0.00292	CcSEcCtD
Tramadol—Abdominal discomfort—Varenicline—nicotine dependence	0.000603	0.00291	CcSEcCtD
Tramadol—Pollakiuria—Varenicline—nicotine dependence	0.000581	0.0028	CcSEcCtD
Tramadol—Erectile dysfunction—Varenicline—nicotine dependence	0.000579	0.00279	CcSEcCtD
Tramadol—Photosensitivity reaction—Varenicline—nicotine dependence	0.000574	0.00277	CcSEcCtD
Tramadol—Hyperglycaemia—Varenicline—nicotine dependence	0.000568	0.00274	CcSEcCtD
Tramadol—Infestation—Varenicline—nicotine dependence	0.000561	0.0027	CcSEcCtD
Tramadol—Infestation NOS—Varenicline—nicotine dependence	0.000561	0.0027	CcSEcCtD
Tramadol—Depression—Varenicline—nicotine dependence	0.000559	0.0027	CcSEcCtD
Tramadol—CHRM3—Monoamine GPCRs—DRD2—nicotine dependence	0.000558	0.0146	CbGpPWpGaD
Tramadol—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.000556	0.00268	CcSEcCtD
Tramadol—Acute coronary syndrome—Varenicline—nicotine dependence	0.000553	0.00267	CcSEcCtD
Tramadol—Myocardial infarction—Varenicline—nicotine dependence	0.00055	0.00265	CcSEcCtD
Tramadol—Stomatitis—Varenicline—nicotine dependence	0.000547	0.00264	CcSEcCtD
Tramadol—SLC6A4—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000547	0.0143	CbGpPWpGaD
Tramadol—Conjunctivitis—Varenicline—nicotine dependence	0.000545	0.00263	CcSEcCtD
Tramadol—HTR2C—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000544	0.0143	CbGpPWpGaD
Tramadol—Hepatobiliary disease—Varenicline—nicotine dependence	0.000531	0.00256	CcSEcCtD
Tramadol—Epistaxis—Varenicline—nicotine dependence	0.000529	0.00255	CcSEcCtD
Tramadol—Sinusitis—Varenicline—nicotine dependence	0.000526	0.00254	CcSEcCtD
Tramadol—OPRM1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000515	0.0135	CbGpPWpGaD
Tramadol—Bradycardia—Varenicline—nicotine dependence	0.000513	0.00247	CcSEcCtD
Tramadol—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00051	0.0134	CbGpPWpGaD
Tramadol—Hypoaesthesia—Varenicline—nicotine dependence	0.000501	0.00242	CcSEcCtD
Tramadol—Hallucination—Varenicline—nicotine dependence	0.000501	0.00242	CcSEcCtD
Tramadol—Urinary tract disorder—Varenicline—nicotine dependence	0.000497	0.0024	CcSEcCtD
Tramadol—Oedema peripheral—Varenicline—nicotine dependence	0.000496	0.00239	CcSEcCtD
Tramadol—Connective tissue disorder—Varenicline—nicotine dependence	0.000495	0.00239	CcSEcCtD
Tramadol—Urethral disorder—Varenicline—nicotine dependence	0.000494	0.00238	CcSEcCtD
Tramadol—Visual impairment—Varenicline—nicotine dependence	0.000485	0.00234	CcSEcCtD
Tramadol—Erythema multiforme—Varenicline—nicotine dependence	0.000476	0.0023	CcSEcCtD
Tramadol—Eye disorder—Varenicline—nicotine dependence	0.000471	0.00227	CcSEcCtD
Tramadol—Tinnitus—Varenicline—nicotine dependence	0.00047	0.00226	CcSEcCtD
Tramadol—CHRM3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000469	0.0123	CbGpPWpGaD
Tramadol—Cardiac disorder—Varenicline—nicotine dependence	0.000467	0.00225	CcSEcCtD
Tramadol—Angiopathy—Varenicline—nicotine dependence	0.000457	0.0022	CcSEcCtD
Tramadol—Immune system disorder—Varenicline—nicotine dependence	0.000455	0.00219	CcSEcCtD
Tramadol—Mediastinal disorder—Varenicline—nicotine dependence	0.000454	0.00219	CcSEcCtD
Tramadol—Chills—Varenicline—nicotine dependence	0.000452	0.00218	CcSEcCtD
Tramadol—Arrhythmia—Varenicline—nicotine dependence	0.00045	0.00217	CcSEcCtD
Tramadol—Mental disorder—Varenicline—nicotine dependence	0.000441	0.00213	CcSEcCtD
Tramadol—Malnutrition—Varenicline—nicotine dependence	0.000438	0.00211	CcSEcCtD
Tramadol—Erythema—Varenicline—nicotine dependence	0.000438	0.00211	CcSEcCtD
Tramadol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000437	0.0115	CbGpPWpGaD
Tramadol—Flatulence—Varenicline—nicotine dependence	0.000432	0.00208	CcSEcCtD
Tramadol—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000431	0.0113	CbGpPWpGaD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00043	0.0113	CbGpPWpGaD
Tramadol—Dysgeusia—Varenicline—nicotine dependence	0.000429	0.00207	CcSEcCtD
Tramadol—Back pain—Varenicline—nicotine dependence	0.000424	0.00204	CcSEcCtD
Tramadol—Muscle spasms—Varenicline—nicotine dependence	0.000421	0.00203	CcSEcCtD
Tramadol—OPRD1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00042	0.011	CbGpPWpGaD
Tramadol—Vision blurred—Varenicline—nicotine dependence	0.000413	0.00199	CcSEcCtD
Tramadol—Tremor—Varenicline—nicotine dependence	0.000411	0.00198	CcSEcCtD
Tramadol—Ill-defined disorder—Varenicline—nicotine dependence	0.000407	0.00196	CcSEcCtD
Tramadol—Anaemia—Varenicline—nicotine dependence	0.000405	0.00195	CcSEcCtD
Tramadol—Agitation—Varenicline—nicotine dependence	0.000403	0.00194	CcSEcCtD
Tramadol—Angioedema—Varenicline—nicotine dependence	0.000401	0.00193	CcSEcCtD
Tramadol—Malaise—Varenicline—nicotine dependence	0.000395	0.00191	CcSEcCtD
Tramadol—Vertigo—Varenicline—nicotine dependence	0.000394	0.0019	CcSEcCtD
Tramadol—Syncope—Varenicline—nicotine dependence	0.000393	0.0019	CcSEcCtD
Tramadol—Palpitations—Varenicline—nicotine dependence	0.000387	0.00187	CcSEcCtD
Tramadol—Loss of consciousness—Varenicline—nicotine dependence	0.000385	0.00186	CcSEcCtD
Tramadol—Cough—Varenicline—nicotine dependence	0.000383	0.00184	CcSEcCtD
Tramadol—Convulsion—Varenicline—nicotine dependence	0.00038	0.00183	CcSEcCtD
Tramadol—Hypertension—Varenicline—nicotine dependence	0.000378	0.00182	CcSEcCtD
Tramadol—Myalgia—Varenicline—nicotine dependence	0.000373	0.0018	CcSEcCtD
Tramadol—Chest pain—Varenicline—nicotine dependence	0.000373	0.0018	CcSEcCtD
Tramadol—Arthralgia—Varenicline—nicotine dependence	0.000373	0.0018	CcSEcCtD
Tramadol—Anxiety—Varenicline—nicotine dependence	0.000372	0.00179	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.000371	0.00179	CcSEcCtD
Tramadol—Discomfort—Varenicline—nicotine dependence	0.000369	0.00178	CcSEcCtD
Tramadol—OPRK1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000369	0.00967	CbGpPWpGaD
Tramadol—Dry mouth—Varenicline—nicotine dependence	0.000365	0.00176	CcSEcCtD
Tramadol—SLC6A4—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000365	0.00957	CbGpPWpGaD
Tramadol—Infection—Varenicline—nicotine dependence	0.000355	0.00171	CcSEcCtD
Tramadol—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000354	0.0093	CbGpPWpGaD
Tramadol—Shock—Varenicline—nicotine dependence	0.000352	0.0017	CcSEcCtD
Tramadol—Nervous system disorder—Varenicline—nicotine dependence	0.000351	0.00169	CcSEcCtD
Tramadol—Thrombocytopenia—Varenicline—nicotine dependence	0.00035	0.00169	CcSEcCtD
Tramadol—Tachycardia—Varenicline—nicotine dependence	0.000349	0.00168	CcSEcCtD
Tramadol—Skin disorder—Varenicline—nicotine dependence	0.000348	0.00168	CcSEcCtD
Tramadol—OPRD1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000347	0.00911	CbGpPWpGaD
Tramadol—Hyperhidrosis—Varenicline—nicotine dependence	0.000346	0.00167	CcSEcCtD
Tramadol—Anorexia—Varenicline—nicotine dependence	0.000341	0.00164	CcSEcCtD
Tramadol—Hypotension—Varenicline—nicotine dependence	0.000334	0.00161	CcSEcCtD
Tramadol—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000331	0.00869	CbGpPWpGaD
Tramadol—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.000326	0.00157	CcSEcCtD
Tramadol—Insomnia—Varenicline—nicotine dependence	0.000324	0.00156	CcSEcCtD
Tramadol—Dyspnoea—Varenicline—nicotine dependence	0.000319	0.00154	CcSEcCtD
Tramadol—Somnolence—Varenicline—nicotine dependence	0.000318	0.00153	CcSEcCtD
Tramadol—Dyspepsia—Varenicline—nicotine dependence	0.000315	0.00152	CcSEcCtD
Tramadol—OPRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000312	0.00818	CbGpPWpGaD
Tramadol—Decreased appetite—Varenicline—nicotine dependence	0.000311	0.0015	CcSEcCtD
Tramadol—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000309	0.00149	CcSEcCtD
Tramadol—Fatigue—Varenicline—nicotine dependence	0.000308	0.00149	CcSEcCtD
Tramadol—Pain—Varenicline—nicotine dependence	0.000306	0.00147	CcSEcCtD
Tramadol—Constipation—Varenicline—nicotine dependence	0.000306	0.00147	CcSEcCtD
Tramadol—OPRK1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000304	0.00798	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000298	0.00781	CbGpPWpGaD
Tramadol—Feeling abnormal—Varenicline—nicotine dependence	0.000295	0.00142	CcSEcCtD
Tramadol—OPRD1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000293	0.00768	CbGpPWpGaD
Tramadol—Gastrointestinal pain—Varenicline—nicotine dependence	0.000293	0.00141	CcSEcCtD
Tramadol—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000287	0.00754	CbGpPWpGaD
Tramadol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000286	0.0075	CbGpPWpGaD
Tramadol—Urticaria—Varenicline—nicotine dependence	0.000284	0.00137	CcSEcCtD
Tramadol—Body temperature increased—Varenicline—nicotine dependence	0.000283	0.00136	CcSEcCtD
Tramadol—Abdominal pain—Varenicline—nicotine dependence	0.000283	0.00136	CcSEcCtD
Tramadol—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000282	0.0074	CbGpPWpGaD
Tramadol—OPRD1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000272	0.00713	CbGpPWpGaD
Tramadol—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.000271	0.0071	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—TAS2R16—nicotine dependence	0.000268	0.00702	CbGpPWpGaD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.000268	0.00702	CbGpPWpGaD
Tramadol—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000267	0.00701	CbGpPWpGaD
Tramadol—Hypersensitivity—Varenicline—nicotine dependence	0.000264	0.00127	CcSEcCtD
Tramadol—Asthenia—Varenicline—nicotine dependence	0.000257	0.00124	CcSEcCtD
Tramadol—OPRK1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000257	0.00674	CbGpPWpGaD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.000256	0.00673	CbGpPWpGaD
Tramadol—Pruritus—Varenicline—nicotine dependence	0.000253	0.00122	CcSEcCtD
Tramadol—Diarrhoea—Varenicline—nicotine dependence	0.000245	0.00118	CcSEcCtD
Tramadol—OPRK1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000238	0.00625	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000238	0.00624	CbGpPWpGaD
Tramadol—Dizziness—Varenicline—nicotine dependence	0.000237	0.00114	CcSEcCtD
Tramadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000233	0.00611	CbGpPWpGaD
Tramadol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000232	0.00608	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—TAS2R16—nicotine dependence	0.00023	0.00605	CbGpPWpGaD
Tramadol—Vomiting—Varenicline—nicotine dependence	0.000227	0.0011	CcSEcCtD
Tramadol—Rash—Varenicline—nicotine dependence	0.000226	0.00109	CcSEcCtD
Tramadol—Dermatitis—Varenicline—nicotine dependence	0.000225	0.00109	CcSEcCtD
Tramadol—Headache—Varenicline—nicotine dependence	0.000224	0.00108	CcSEcCtD
Tramadol—SLC6A4—Circadian rythm related genes—DRD2—nicotine dependence	0.00022	0.00578	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000216	0.00566	CbGpPWpGaD
Tramadol—Nausea—Varenicline—nicotine dependence	0.000213	0.00102	CcSEcCtD
Tramadol—OPRD1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000212	0.00555	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000208	0.00547	CbGpPWpGaD
Tramadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000204	0.00536	CbGpPWpGaD
Tramadol—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0002	0.00524	CbGpPWpGaD
Tramadol—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000196	0.00515	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000189	0.00496	CbGpPWpGaD
Tramadol—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000188	0.00494	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.000186	0.00489	CbGpPWpGaD
Tramadol—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000186	0.00487	CbGpPWpGaD
Tramadol—OPRK1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000186	0.00487	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.000177	0.00465	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000176	0.00462	CbGpPWpGaD
Tramadol—HTR2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000173	0.00454	CbGpPWpGaD
Tramadol—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000172	0.00452	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—FGD1—nicotine dependence	0.000169	0.00444	CbGpPWpGaD
Tramadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000168	0.00442	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000166	0.00434	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—FGD1—nicotine dependence	0.000163	0.00429	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00016	0.0042	CbGpPWpGaD
Tramadol—OPRM1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000157	0.00412	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—OPRM1—nicotine dependence	0.000155	0.00408	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000151	0.00397	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000149	0.00391	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—FGD1—nicotine dependence	0.000148	0.0039	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000148	0.00389	CbGpPWpGaD
Tramadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000148	0.00387	CbGpPWpGaD
Tramadol—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000146	0.00382	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000138	0.00363	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000137	0.0036	CbGpPWpGaD
Tramadol—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000131	0.00343	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00013	0.00342	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000128	0.00336	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000128	0.00335	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000127	0.00334	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000125	0.00329	CbGpPWpGaD
Tramadol—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000125	0.00328	CbGpPWpGaD
Tramadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000125	0.00327	CbGpPWpGaD
Tramadol—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000123	0.00323	CbGpPWpGaD
Tramadol—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000121	0.00318	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000119	0.00311	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.000118	0.0031	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000113	0.00296	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—DRD2—nicotine dependence	0.000112	0.00295	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TAS2R16—nicotine dependence	0.000112	0.00293	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000108	0.00283	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000108	0.00282	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000107	0.00281	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—FGD1—nicotine dependence	0.000102	0.00268	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—OPRM1—nicotine dependence	0.0001	0.00263	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—FGD1—nicotine dependence	0.0001	0.00262	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—OPRM1—nicotine dependence	9.71e-05	0.00255	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—DRD2—nicotine dependence	9.5e-05	0.00249	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TAS2R16—nicotine dependence	9.45e-05	0.00248	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—FGD1—nicotine dependence	9.28e-05	0.00243	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.22e-05	0.00242	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—OPRM1—nicotine dependence	9.1e-05	0.00239	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—AKR1B10—nicotine dependence	8.83e-05	0.00232	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—OPRM1—nicotine dependence	8.78e-05	0.0023	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—FGD1—nicotine dependence	8.77e-05	0.0023	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	8.15e-05	0.00214	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	8.11e-05	0.00213	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—OPRM1—nicotine dependence	7.98e-05	0.00209	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—AKR1B10—nicotine dependence	7.75e-05	0.00203	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—FGD1—nicotine dependence	7.41e-05	0.00195	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—DRD2—nicotine dependence	7.24e-05	0.0019	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	7.02e-05	0.00184	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	6.98e-05	0.00183	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—DRD2—nicotine dependence	6.58e-05	0.00173	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—AKR1B10—nicotine dependence	6.55e-05	0.00172	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	6.37e-05	0.00167	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—FGD1—nicotine dependence	6.36e-05	0.00167	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—DRD2—nicotine dependence	6.35e-05	0.00167	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—WASF2—nicotine dependence	6.22e-05	0.00163	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—WASF1—nicotine dependence	5.97e-05	0.00157	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	5.79e-05	0.00152	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—DRD2—nicotine dependence	5.77e-05	0.00151	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	5.62e-05	0.00148	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	5.49e-05	0.00144	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—FGD1—nicotine dependence	5.48e-05	0.00144	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—WASF2—nicotine dependence	5.46e-05	0.00143	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CYP2A7—nicotine dependence	5.38e-05	0.00141	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—OPRM1—nicotine dependence	5.37e-05	0.00141	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—DRD2—nicotine dependence	5.37e-05	0.00141	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—WASF1—nicotine dependence	5.23e-05	0.00137	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	4.98e-05	0.00131	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—DRD2—nicotine dependence	4.87e-05	0.00128	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	4.84e-05	0.00127	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—OPRM1—nicotine dependence	4.71e-05	0.00124	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CYP2A7—nicotine dependence	4.63e-05	0.00122	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—WASF2—nicotine dependence	4.61e-05	0.00121	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	4.61e-05	0.00121	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—WASF1—nicotine dependence	4.42e-05	0.00116	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	4.18e-05	0.0011	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	3.97e-05	0.00104	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—WASF2—nicotine dependence	3.96e-05	0.00104	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—DRD2—nicotine dependence	3.88e-05	0.00102	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—WASF1—nicotine dependence	3.8e-05	0.000997	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	3.6e-05	0.000946	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	3.42e-05	0.000897	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—WASF2—nicotine dependence	3.41e-05	0.000895	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—DRD2—nicotine dependence	3.41e-05	0.000894	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—WASF1—nicotine dependence	3.27e-05	0.000858	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CYP2A7—nicotine dependence	3.22e-05	0.000844	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	2.94e-05	0.000773	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—DRD2—nicotine dependence	2.88e-05	0.000755	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—DRD2—nicotine dependence	2.47e-05	0.000649	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—DRD2—nicotine dependence	2.13e-05	0.000559	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2.1e-05	0.000552	CbGpPWpGaD
